Ranibizumab Intraocular and Trazodone Extended-Release Tablets
Determining the interaction of Ranibizumab Intraocular and Trazodone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: trazodone
Brand name: Desyrel, Desyrel Dividose, Oleptro
Synonyms: Trazodone, TraZODone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Trazodone Hydrochloride
- Ranibizumab Intraocular-Trazodone Oral
- Ranibizumab Intraocular-Trazodone Tablets
- Ranibizumab Intraocular-Treanda
- Ranibizumab Intraocular-Trecator
- Ranibizumab Intraocular-Trecator-SC
- Trazodone Extended-Release Tablets-Ranibizumab ophthalmic
- Trazodone Extended-Release Tablets-Ranitidine
- Trazodone Extended-Release Tablets-Ranitidine Capsule
- Trazodone Extended-Release Tablets-Ranitidine Hydrochloride
- Trazodone Extended-Release Tablets-Ranitidine Injection
- Trazodone Extended-Release Tablets-Ranitidine Suspension